The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair

Objective: This study aims to explore the role of MARK2 in chemotherapeutic resistance and potential mechanism within cisplatin resistance models of CD133+ MG-63 and MNNG/HOS cells. Methods: CD133− and CD133+ MG-63 and MNNG/HOS cells were differentiated and obtained by MACS(Magnetic bead sorting). C...

Full description

Bibliographic Details
Main Authors: Liang Xu, Zhengkao Sun, Xianfu Wei, Hongdong Tan, Peng Kong, Zhenfeng Li, Qiang Yang, E'nuo Dai, Jianmin Li
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Journal of Bone Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137420300452